A clinical approach to diagnosis of autoimmune encephalitis
Tóm tắt
Từ khóa
Tài liệu tham khảo
Venkatesan, 2013, Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium, Clin Infect Dis, 57, 1114, 10.1093/cid/cit458
Jmor, 2008, The incidence of acute encephalitis syndrome in Western industrialised and tropical countries, Virol J, 5, 134, 10.1186/1743-422X-5-134
Vora, 2014, Burden of encephalitis-associated hospitalizations in the United States, 1998–2010, Neurology, 82, 443, 10.1212/WNL.0000000000000086
Ball, 2002, Development of case definitions for acute encephalopathy, encephalitis, and multiple sclerosis reports to the vaccine: Adverse Event Reporting System, J Clin Epidemiol, 55, 819, 10.1016/S0895-4356(01)00500-5
Sejvar, 2007, Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data, Vaccine, 25, 5771, 10.1016/j.vaccine.2007.04.060
Britton, 2015, Consensus guidelines for the investigation and management of encephalitis in adults and children in Australia and New Zealand, Intern Med J, 45, 563, 10.1111/imj.12749
Alamowitch, 1997, Limbic encephalitis and small cell lung cancer. Clinical and immunological features, Brain, 120, 923, 10.1093/brain/120.6.923
Dalmau, 2004, Clinical analysis of anti-Ma2-associated encephalitis, Brain, 127, 1831, 10.1093/brain/awh203
Malter, 2010, Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis, Ann Neurol, 67, 470, 10.1002/ana.21917
Dalmau, 2011, Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis, Lancet Neurol, 10, 63, 10.1016/S1474-4422(10)70253-2
Lai, 2009, AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location, Ann Neurol, 65, 424, 10.1002/ana.21589
Lancaster, 2010, Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen, Lancet Neurol, 9, 67, 10.1016/S1474-4422(09)70324-2
Petit-Pedrol, 2014, Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies, Lancet Neurol, 13, 276, 10.1016/S1474-4422(13)70299-0
Lancaster, 2011, Antibodies to metabotropic glutamate receptor 5 in the Ophelia syndrome, Neurology, 77, 1698, 10.1212/WNL.0b013e3182364a44
Dale, 2012, Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders, Brain, 135, 3453, 10.1093/brain/aws256
Lai, 2010, Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series, Lancet Neurol, 9, 776, 10.1016/S1474-4422(10)70137-X
Irani, 2010, Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia, Brain, 133, 2734, 10.1093/brain/awq213
Boronat, 2013, Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels, Ann Neurol, 73, 120, 10.1002/ana.23756
Brilot, 2009, Antibodies to native myelin oligodendrocyte glycoprotein in children with inflammatory demyelinating central nervous system disease, Ann Neurol, 66, 833, 10.1002/ana.21916
McKeon, 2008, CNS aquaporin-4 autoimmunity in children, Neurology, 71, 93, 10.1212/01.wnl.0000314832.24682.c6
Shahrizaila, 2013, Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome, J Neurol Neurosurg Psychiatry, 84, 576, 10.1136/jnnp-2012-302824
Ariño, 2015, Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies, JAMA Neurol, 72, 874, 10.1001/jamaneurol.2015.0749
Alexopoulos, 2013, Immunology of stiff person syndrome and other GAD-associated neurological disorders, Expert Rev Clin Immunol, 9, 1043, 10.1586/1744666X.2013.845527
Carvajal-González, 2014, Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes, Brain, 137, 2178, 10.1093/brain/awu142
Demarquay, 2011, Clinical presentation of immune-mediated cerebellar ataxia, Rev Neurol (Paris), 167, 408, 10.1016/j.neurol.2010.07.032
Zuliani, 2012, Central nervous system neuronal surface antibody associated syndromes: review and guidelines for recognition, J Neurol Neurosurg Psychiatry, 83, 638, 10.1136/jnnp-2011-301237
Titulaer, 2013, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study, Lancet Neurol, 12, 157, 10.1016/S1474-4422(12)70310-1
Byrne, 2015, Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome, Neurol Neuroimmunol Neuroinflamm, 2, e130, 10.1212/NXI.0000000000000130
Ances, 2005, Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates, Brain, 128, 1764, 10.1093/brain/awh526
Vincent, 2004, Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis, Brain, 127, 701, 10.1093/brain/awh077
Krupp, 2013, International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions, Mult Scler, 19, 1261, 10.1177/1352458513484547
Irani, 2012, Morvan syndrome: clinical and serological observations in 29 cases, Ann Neurol, 72, 241, 10.1002/ana.23577
Bien, 2005, Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement, Brain, 128, 454, 10.1093/brain/awh415
Armangue, 2012, Autoimmune encephalitis in children, J Child Neurol, 27, 1460, 10.1177/0883073812448838
Pillai, 2015, Infectious and autoantibody-associated encephalitis: clinical features and long-term outcome, Pediatrics, 135, e974, 10.1542/peds.2014-2702
Schmitt, 2012, Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis, Neurology, 79, 1094, 10.1212/WNL.0b013e3182698cd8
Weil, 2002, Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result, Clin Infect Dis, 34, 1154, 10.1086/339550
Solomon, 2012, Management of suspected viral encephalitis in adults—association of British Neurologists and British Infection Association National Guidelines, J Infect, 64, 347, 10.1016/j.jinf.2011.11.014
Tobin, 2014, DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients, Neurology, 83, 1797, 10.1212/WNL.0000000000000991
Irani, 2011, Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis, Ann Neurol, 69, 892, 10.1002/ana.22307
Wakerley, 2014, Guillain-Barré and Miller Fisher syndromes—new diagnostic classification, Nat Rev Neurol, 10, 537, 10.1038/nrneurol.2014.138
Baumgartner, 2013, Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types, J Neurol, 260, 2744, 10.1007/s00415-013-7048-2
Heine, 2015, Imaging of autoimmune encephalitis – Relevance for clinical practice and hippocampal function, Neuroscience, 309, 68, 10.1016/j.neuroscience.2015.05.037
Gultekin, 2000, Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients, Brain, 123, 1481, 10.1093/brain/123.7.1481
Graus, 2004, Recommended diagnostic criteria for paraneoplastic neurological syndromes, J Neurol Neurosurg Psychiatry, 75, 1135, 10.1136/jnnp.2003.034447
Graus, 2008, Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations, Neurology, 71, 930, 10.1212/01.wnl.0000325917.48466.55
Najjar, 2011, Spontaneously resolving seronegative autoimmune limbic encephalitis, Cogn Behav Neurol, 24, 99, 10.1097/WNN.0b013e3182248193
Voltz, 1999, A serologic marker of paraneoplastic limbic and brain-stem encephalitis in patients with testicular cancer, N Engl J Med, 340, 1788, 10.1056/NEJM199906103402303
Höftberger, 2013, Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients, Neurology, 81, 1500, 10.1212/WNL.0b013e3182a9585f
Höftberger, 2015, Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients, Neurology, 84, 2403, 10.1212/WNL.0000000000001682
Malter, 2014, Outcome of limbic encephalitis with VGKC-complex antibodies: relation to antigenic specificity, J Neurol, 261, 1695, 10.1007/s00415-014-7408-6
Jarius, 2008, CSF findings in patients with voltage gated potassium channel antibody associated limbic encephalitis, J Neurol Sci, 268, 74, 10.1016/j.jns.2007.11.004
Athauda, 2014, High grade glioma mimicking voltage gated potassium channel complex associated antibody limbic encephalitis, Case Rep Neurol Med, 2014, 458790
Chevret, 2008, Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality, J Neurol, 255, 112, 10.1007/s00415-008-0713-1
Chow, 2015, Use of clinical and neuroimaging characteristics to distinguish temporal lobe herpes simplex encephalitis from its mimics, Clin Infect Dis, 60, 1377
Seeley, 2007, Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6, Neurology, 69, 156, 10.1212/01.wnl.0000265591.10200.d7
Renard, 2015, DWI and FLAIR imaging in herpes simplex encephalitis: a comparative and topographical analysis, J Neurol, 262, 2101, 10.1007/s00415-015-7818-0
Jeffery, 2013, GABAB receptor autoantibody frequency in service serologic evaluation, Neurology, 81, 882, 10.1212/WNL.0b013e3182a35271
Wingerchuk, 2006, The clinical course of acute disseminated encephalomyelitis, Neurol Res, 28, 341, 10.1179/016164106X98251
Wingerchuk, 2003, Postinfectious encephalomyelitis, Curr Neurol Neurosci Rep, 3, 256, 10.1007/s11910-003-0086-x
Karussis, 2014, The spectrum of post-vaccination inflammatory CNS demyelinating syndromes, Autoimmun Rev, 13, 215, 10.1016/j.autrev.2013.10.003
Wingerchuk, 2013, Acute disseminated encephalomyelitis, transverse myelitis, and neuromyelitis optica, Continuum (Minneap Minn), 19, 944
Kesselring, 1990, Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis, Brain, 113, 291, 10.1093/brain/113.2.291
Baumann, 2015, Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein, J Neurol Neurosurg Psychiatry, 86, 265, 10.1136/jnnp-2014-308346
Huppke, 2013, Acute disseminated encephalomyelitis followed by recurrent or monophasic optic neuritis in pediatric patients, Mult Scler, 19, 941, 10.1177/1352458512466317
Reindl, 2013, The spectrum of MOG autoantibody-associated demyelinating diseases, Nat Rev Neurol, 9, 455, 10.1038/nrneurol.2013.118
Dörr, 2013, Characteristics of Susac syndrome: a review of all reported cases, Nat Rev Neurol, 9, 307, 10.1038/nrneurol.2013.82
Moscato, 2014, Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis, Ann Neurol, 76, 108, 10.1002/ana.24195
Planagumà, 2015, Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice, Brain, 138, 94, 10.1093/brain/awu310
Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol, 7, 1091, 10.1016/S1474-4422(08)70224-2
Viaccoz, 2014, Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis, Neurology, 82, 556, 10.1212/WNL.0000000000000126
Gresa-Arribas, 2014, Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study, Lancet Neurol, 13, 167, 10.1016/S1474-4422(13)70282-5
Zandi, 2015, Clinical relevance of serum antibodies to extracellular N-methyl-D-aspartate receptor epitopes, J Neurol Neurosurg Psychiatry, 86, 708, 10.1136/jnnp-2014-308736
Wang, 2015, CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis, Seizure, 29, 137, 10.1016/j.seizure.2015.04.005
Prüss, 2012, N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis, Ann Neurol, 72, 902, 10.1002/ana.23689
Armangue, 2014, Herpes simplex virus encephalitis is a trigger of brain autoimmunity, Ann Neurol, 75, 317, 10.1002/ana.24083
Hacohen, 2014, N-methyl-D-aspartate receptor antibodies in post-herpes simplex virus encephalitis neurological relapse, Mov Disord, 29, 90, 10.1002/mds.25626
Armangue, 2015, Autoimmune post-herpes simplex encephalitis of adults and teenagers, Neurology, 85, 1736, 10.1212/WNL.0000000000002125
Mohammad, 2014, Herpes simplex encephalitis relapse with chorea is associated with autoantibodies to N-Methyl-D-aspartate receptor or dopamine-2 receptor, Mov Disord, 29, 117, 10.1002/mds.25623
Koga, 2012, Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristics, J Neurol Neurosurg Psychiatry, 83, 1210, 10.1136/jnnp-2012-303060
Odaka, 2003, Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain-Barré syndrome, Brain, 126, 2279, 10.1093/brain/awg233
Merwick, 2013, Insights into antibody-associated encephalitis—Bickerstaff's 1950's papers revisited, J Neurol Sci, 334, 167, 10.1016/j.jns.2013.07.010
Moragas, 2011, Rhombencephalitis: a series of 97 patients, Medicine (Baltimore), 90, 256, 10.1097/MD.0b013e318224b5af
Pittock, 2010, Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS), Brain, 133, 2626, 10.1093/brain/awq164
Wang, 2009, Enterovirus 71: epidemiology, pathogenesis and management, Expert Rev Anti Infect Ther, 7, 735, 10.1586/eri.09.45
Gleichman, 2012, Anti-NMDA receptor encephalitis antibody binding is dependent on amino acid identity of a small region within the GluN1 amino terminal domain, J Neurosci, 32, 11082, 10.1523/JNEUROSCI.0064-12.2012
Takahashi, 2005, Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen's encephalitis and chronic progressive epilepsia partialis continua, Epilepsia, 46, 152, 10.1111/j.1528-1167.2005.01024.x
Huda, 2015, An 11-year retrospective experience of antibodies against the voltage-gated potassium channel (VGKC) complex from a tertiary neurological centre, J Neurol, 262, 418, 10.1007/s00415-014-7588-0
Paterson, 2014, Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre, J Neurol Neurosurg Psychiatry, 85, 625, 10.1136/jnnp-2013-305218
Klein, 2013, Insights from LGI1 and CASPR2 potassium channel complex autoantibody subtyping, JAMA Neurol, 70, 229, 10.1001/jamaneurol.2013.592
Dahm, 2014, Seroprevalence of autoantibodies against brain antigens in health and disease, Ann Neurol, 76, 82, 10.1002/ana.24189
Armangue, 2015, When a serum test overrides the clinical assessment, Neurology, 84, 1379, 10.1212/WNL.0000000000001425
Titulaer, 2014, Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis, Ann Neurol, 75, 411, 10.1002/ana.24117
Jarius, 2011, Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures, J Neurol Sci, 306, 82, 10.1016/j.jns.2011.03.038
Meinck, 2001, Antibodies against glutamic acid decarboxylase: prevalence in neurological diseases, J Neurol Neurosurg Psychiatry, 71, 100, 10.1136/jnnp.71.1.100
Saiz, 2008, Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association, Brain, 131, 2553, 10.1093/brain/awn183
Hollowell, 2002, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III), J Clin Endocrinol Metab, 87, 489, 10.1210/jcem.87.2.8182
Castillo, 2006, Steroid-responsive encephalopathy associated with autoimmune thyroiditis, Arch Neurol, 63, 197, 10.1001/archneur.63.2.197
Tardieu, 2013, Rare inflammatory diseases of the white matter and mimics of multiple sclerosis and related disorders, Neuropediatrics, 44, 302, 10.1055/s-0033-1358599
Chong, 2003, Hashimoto encephalopathy: syndrome or myth?, Arch Neurol, 60, 164, 10.1001/archneur.60.2.164
Yoneda, 2007, High prevalence of serum autoantibodies against the amino terminal of alpha-enolase in Hashimoto's encephalopathy, J Neuroimmunol, 185, 195, 10.1016/j.jneuroim.2007.01.018
Servettaz, 2008, Natural anti-endothelial cell antibodies, Autoimmun Rev, 7, 426, 10.1016/j.autrev.2008.03.010
Pettingill, 2015, Antibodies to GABAA receptor α1 and γ2 subunits: clinical and serologic characterization, Neurology, 84, 1233, 10.1212/WNL.0000000000001326